In accordance with its commitment to patient safety, Medtronic recently voluntarily recalled a subset of its IN.PACT Admiral and IN.PACT AV Paclitaxel-coated Percutaneous Transluminal Angioplasty (PTA) balloon catheters due to the potential for pouch damage resulting in a loss of sterility.
News | Drug-Eluting Balloons
Medtronic Issues Voluntary Recall for Subset of IN.PACT Admiral and IN.PACT AV Drug Coated Balloon

March 31, 2022 — In accordance with its commitment to patient safety, Medtronic recently voluntarily recalled a subset ...

Home March 31, 2022
Home
MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: Most Read Cardiology Content in March 2022

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...

Home March 31, 2022
Home
Low-Res_EHJ.jpg
News | Heart Failure
Bone Marrow Contributes to the Development of Atherosclerosis
April 1, 2022 – The activation of the bone marrow appears to play a key role in the origin and development of ...
Home March 31, 2022
Home
Stereotaxis’ Genesis Robotic Magnetic Navigation (RMN) system
News | Robotic Systems
National Institute of Cardiology Becomes First Hospital in Poland to Establish Advanced Robotic Program to Treat Heart Rhythm Disorders
April 1, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac ...
Home March 31, 2022
Home
The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held April 3-5 at the Bella Center in Copenhagen, Denmark and online. Explore the scientific program.
News | ESC
EHRA 2022: Cutting Edge Science in Heart Rhythm Disorders

March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held ...

Home March 31, 2022
Home
COVID-19 patient
News | Coronavirus (COVID-19)
International Multi-center Study Confirms Stroke Risk in Younger Healthier COVID-19 Patients
April 1, 2022 – Over the course of the pandemic, a number of studies examined whether COVID-19 patients were at ...
Home March 31, 2022
Home
Study researchers
News | Population Health
Living Near Green Areas Reduces the Risk of Suffering a Stroke by 16%

April 1, 2022 – The risk of suffering an ischemic stroke, the most common type of cerebrovascular event, is 16% less in ...

Home March 31, 2022
Home
Investigators from Cedars-Sinai have created an artificial intelligence-enabled tool that may make it easier to predict if a person will have a heart attack.
News | CT Angiography (CTA)
Artificial Intelligence Tool May Help Predict Heart Attacks

March 31, 2022 – Investigators from Cedars-Sinai have created an artificial intelligence-enabled tool that may make it ...

Home March 31, 2022
Home
DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software, announced today a multi-year agreement with Change Healthcare, a global industry-leading provider of enterprise imaging solutions.
News | Cardiovascular Ultrasound
DiA Imaging Analysis Teams up with Healthcare Technology Company to Expand its AI Offering for Echo-lab Cardiac Exams
March 31, 2022 – DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software ...
Home March 31, 2022
Home
Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced it has successfully completed enrollment in its phase 2 study of istaroxime in early cardiogenic shock caused by heart failure.
News | Pharmaceuticals
Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic Shock
March 31, 2022 – Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions ...
Home March 31, 2022
Home
Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the publication of results from the first-in-human clinical trial of Embrace Hydrogel Embolic System (HES) for the treatment of hypervascular tumors, in the Journal of Vascular and Interventional Radiology (JVIR).
News | Embolization devices
Instylla First-In-Human Clinical Trial Published Results Demonstrate Technical Success and Persistent Embolization Across All Patients
March 31, 2022 – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...
Home March 31, 2022
Home
Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the first patient was treated in a U.S. early feasibility study evaluating PerQseal+, the next generation of the company’s PerQseal device.
News | Structural Heart
Vivasure Medical Announces First Patient Treated in U.S. Early Feasibility Study Evaluating PerQseal+
March 31, 2022 – Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...
Home March 31, 2022
Home
One in 5 people worldwide have high Lipoprotein(a) – sometimes referred to as “L-P-little a” – an important genetic risk factor for premature heart disease and stroke.
News | Heart Failure
The Silent, Undetected Cause of Early Heart Disease

March 31, 2022 – One in 5 people worldwide have high Lipoprotein(a) – sometimes referred to as “L-P-little a” – an ...

Home March 31, 2022
Home
University Hospitals Cleveland Medical Center
News | Population Health
Study Shows Link Between Socioeconomic Deprivation and Premature Cardiovascular Mortality

March 31, 2022 – People living in socially-deprived areas of the United States are more likely to die prematurely from ...

Home March 31, 2022
Home
A study conducted at São Paulo State University (UNESP) in Brazil shows that even mild to moderate infection by SARS-CoV-2 can cause an imbalance in the cardiovascular system of young adults without pre-existing diseases.
News | Coronavirus (COVID-19)
Study: Even Mild or Moderate COVID-19 Can Affect the Cardiovascular System in Young Adults

March 31, 2022 – A study conducted at São Paulo State University (UNESP) in Brazil shows that even mild to moderate ...

Home March 31, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now